Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2011
07/20/2011CN101449659B Environment regulating agent and production method thereof
07/20/2011CN101434627B 2'-fluoro-4'-substituted nucleoside analogue, synthetic method and use thereof
07/20/2011CN101422469B Use of terramycin in preparing medicine for treating aquatic animal spiroplasmosis
07/20/2011CN101418017B Method for synthesizing (R)-9-(2-phosphate methoxy propyl)adenine
07/20/2011CN101401848B Composition for treating acute, chronic hepatitis and fatty liver
07/20/2011CN101397572B Method for rescuing influenza virus and bidirectional transcription vector special therefor
07/20/2011CN101376640B Low irritation garlicin derivative, and synthetic method and use thereof
07/20/2011CN101361980B Heparin phospholipid composite suitable for non-injection administration and preparation method thereof
07/20/2011CN101322779B Chinese medicine for treating mammitis of milk cattle and preparation thereof
07/20/2011CN101322726B Use of Chinese medicine preparation containing Hippochaete ramosissimum total flavones for preparing medicament for treating hepatitis
07/20/2011CN101317893B Xuebijing oral administration effervescing agent
07/20/2011CN101288682B Microemulsion containing brucea javanica oil and preparation method thereof
07/20/2011CN101244036B High dispersion does type containing cholesterol group phosphoryl nucleoside analogue
07/20/2011CN101234147B Method of preparing total flavones of tropaeolum for injections
07/20/2011CN101215576B Rabbit viral haemorrhagic virus capsid protein gene recombination baculovirus and vaccine
07/20/2011CN101214367B Chinese medicine for treating manus and tinea pedis
07/20/2011CN101199630B Drug for treating hepatitis B
07/20/2011CN101185722B Infusion medicine for treating beriberi
07/20/2011CN101167841B Medicine for curing venereal disease and inflammation
07/20/2011CN101113177B Method for separating and purifying anti-hepatitis B immune globulin from plasma or plasma component
07/20/2011CN101085043B Method for preparing forsythia suspense extraction
07/20/2011CN101073595B Glycyrrhiza total flavonoid and total saponin extract and its production
07/20/2011CN101040953B Injection for treating hepatitis and its preparing process
07/19/2011US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
07/19/2011US7982034 Prodrugs of heteroaryl compounds
07/19/2011US7982025 Fusion proteins of Mycobacterium tuberculosis
07/19/2011US7981879 HIV integrase inhibitors
07/19/2011US7981859 Including teicoplanin which shares many chemical and microbiological characteristics with vancomycin, but which possesses higher activity against many Gram-positive bacteria and is less nephrotoxic
07/19/2011US7981676 Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins
07/19/2011US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases
07/19/2011US7981601 Method of preparing polyepitope chimeric gene vaccine
07/19/2011US7981448 Method of treating necrotizing enterocolitis in a patient, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient.
07/19/2011US7981427 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43
07/19/2011US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
07/19/2011CA2647346C Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
07/19/2011CA2637774C Nucleosides with anti-hepatitis b virus activity
07/19/2011CA2570758C Shaped implant material with antibiotic salts
07/19/2011CA2485702C Novel phosphonic acid based prodrugs of pmea and its analogues
07/19/2011CA2465272C Separation of regioisomers of metal phthalocyanines
07/19/2011CA2459165C Dosage forms having prolonged active ingredient release
07/19/2011CA2452239C Pharmaceutical formulation having a masked taste and method for the production thereof
07/19/2011CA2441996C Non-nucleoside reverse transcriptase inhibitors
07/19/2011CA2417388C Therapeutic polyanhydride compounds for drug delivery
07/19/2011CA2336445C Glycopeptide derivatives and pharmaceutical compositions containing the same
07/14/2011WO2011085326A1 D- amino acids for use in treating biofilms
07/14/2011WO2011085231A2 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
07/14/2011WO2011085130A1 Solid state forms of fosamprenavir calcium salt and process for preparation thereof
07/14/2011WO2011085070A2 Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts
07/14/2011WO2011084967A2 Methods and compositions for providing protective immunity in the elderly
07/14/2011WO2011084962A1 Analogs of dehydrophenylahistins
07/14/2011WO2011084922A1 Pro-drugs of (e) -7- (3- (2-amino-1-fluoroethylidene) piperidin-1-yl) -1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/14/2011WO2011084882A2 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
07/14/2011WO2011084726A1 BIS [4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM] 4-[(3-CARBOXYLATO-2-HYDROXYNAPHTHALEN-1-YL)METHYL]-3-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS
07/14/2011WO2011084725A1 4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM 1-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS
07/14/2011WO2011084610A1 Liposomes for preventing the spread of hiv
07/14/2011WO2011084366A2 Methods, compositions and drug delivery systems for intraocular delivery of sirna molecules
07/14/2011WO2011083317A1 Ev576 for use in the treatment of viral infections of the respiratory tract
07/14/2011WO2011082835A1 New synergistic compositions for the treatment of topical viral infections
07/14/2011WO2011050384A3 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
07/14/2011WO2011045682A3 Active agent containing polymer network delivery composition and articles using the same
07/14/2011WO2011045681A3 Carbohydrate entrapped active agent delivery composition and articles using the same
07/14/2011WO2011028492A3 Sortase a inhibitors
07/14/2011WO2011028485A3 Tumoricidal, bactericidal, or viricidal macrophage activation
07/14/2011WO2011028064A3 Novel bacteriophage and antibacterial composition comprising the same
07/14/2011WO2011028061A3 Novel bacteriophage and antibacterial composition comprising the same
07/14/2011WO2011028059A3 Novel bacteriophage and antibacterial composition comprising the same
07/14/2011WO2011028057A3 Novel bacteriophage and antibacterial composition comprising the same
07/14/2011WO2011020913A3 Cyclodepsipeptide antiviral compounds
07/14/2011US20110172580 Wound care dressing
07/14/2011US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
07/14/2011US20110172311 Compounds For Treating Human Papillomavirus
07/14/2011US20110172292 Antidote oligomers
07/14/2011US20110172289 Minor groove binder (mgb)-oligonucleotide mirna antagonists
07/14/2011US20110172285 Proteasome inhibitors
07/14/2011US20110172281 Anti-Viral Drugs for Treatment of Arenavirus Infection
07/14/2011US20110172274 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity
07/14/2011US20110172265 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
07/14/2011US20110172261 DIBENZO[f,h]ISOQUINOLINE DERIVATIVES
07/14/2011US20110172238 Benzimidazole analogues for the treatment or prevention of flavivirus infections
07/14/2011US20110172231 2,4- diaminopyrimidine derivatives
07/14/2011US20110172225 Antifungal agents
07/14/2011US20110172216 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
07/14/2011US20110172212 Amine-based compound and use thereof
07/14/2011US20110172207 Substituted pyrazolamides and their use
07/14/2011US20110172202 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
07/14/2011US20110172201 Process for preparing a carbapenem antibiotic composition
07/14/2011US20110172200 Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics
07/14/2011US20110172193 Pro-drugs of (e)-7-(3-(2-amino-1-fluoroethylidene)piperidin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/14/2011US20110172187 Boron-containing small molecules
07/14/2011US20110172178 Beta-l-2' deoxynucleosides for the treatment of resistant hbv strains and combination therapies
07/14/2011US20110172174 Antibacterial agents
07/14/2011US20110172169 Method of Detection of Nucleic Acids with a Specific Sequence Composition
07/14/2011US20110172160 Heat-stable, aqueous lactoferrin composition and its preparation and use
07/14/2011US20110172157 Somatostatin analogues
07/14/2011US20110172145 Antimicrobial compounds
07/14/2011US20110172143 Method of modulating cell survival and reagents useful for same
07/14/2011US20110171316 Expression and assembly of human group c rotavirus-like particles and uses thereof
07/14/2011US20110171315 Oral recombinant helicobacter pylori vaccine and preparing method thereof
07/14/2011US20110171308 Ph-sensitive solid pharmaceutical composition for oral preparation and preparation method thereof
07/14/2011US20110171304 Injectable beta-hairpin peptide hydrogel that kills methicillin-resistant staphylococcus aureus